Voxel finds new Voxcam vendor
Holographic display developer Voxel has signed on Kaiser Electro-Optics as a key vendor in its Voxcam imager redesign program. Carlsbad, CA-based KEO, a subsidiary of Kaiser Aerospace & Electronics, has begun design work on the optical subsystem for
Holographic display developer Voxel has signed on Kaiser Electro-Optics as a key vendor in its Voxcam imager redesign program. Carlsbad, CA-based KEO, a subsidiary of Kaiser Aerospace & Electronics, has begun design work on the optical subsystem for the new Voxcam and is expected to begin deliveries in 1999, said Raymond Schulz, director of marketing at Voxel.
The company's dispute with former Voxcam vendor General Scanning is now in the hands of arbitrators (SCAN 12/17/97). Schulz expects a decision to be handed down by the three-judge arbitration panel no later than June.
In other Voxel news, the company's Voxcam unit at the Department of Veteran Affairs Joint Imaging Service at the New Mexico Regional Federal Medical Center is in routine clinical use. The beta unit, the first to be installed by the Laguna Hills, CA-based company, is being used in four to six cases per day, Schulz said.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
